about
Influence of immune activation and inflammatory response on cardiovascular risk associated with the human immunodeficiency virusThe biology of atherosclerosis: general paradigms and distinct pathogenic mechanisms among HIV-infected patientsMonocytes as regulators of inflammation and HIV-related comorbidities during cARTMarkers of coagulation and inflammation often remain elevated in ART-treated HIV-infected patientsArterial disease in patients with human immunodeficiency virus infection: what has imaging taught us?The roles of HIV-1 proteins and antiretroviral drug therapy in HIV-1-associated endothelial dysfunctionInflammatory and coagulation biomarkers and mortality in patients with HIV infectionLevels of soluble endothelial protein C receptor are associated with CD4+ changes in Maraviroc-treated HIV-infected patientsSurveillance monitoring for safety of in utero antiretroviral therapy exposures: current strategies and challenges.Acute systemic inflammation induced by influenza A (H1N1) vaccination causes a deterioration in endothelial function in HIV-infected patients.Breast cancer, dermatofibromas and arsenic.Coagulation and morbidity in treated HIV infection.Combination antiretroviral therapy modulates the blood oxygen level-dependent amplitude in human immunodeficiency virus-seropositive patients.Microbial translocation and cardiometabolic risk factors in HIV infection.The consequences of HIV infection and antiretroviral therapy use for cardiovascular disease risk: shifting paradigms.Initiation of antiretroviral therapy at higher nadir CD4+ T-cell counts is associated with reduced arterial stiffness in HIV-infected individuals.No impairment of endothelial function or insulin sensitivity with 4 weeks of the HIV protease inhibitors atazanavir or lopinavir-ritonavir in healthy subjects without HIV infection: a placebo-controlled trialHigh-fat meals do not impair postprandial endothelial function in HIV-infected and uninfected menRelationship of body composition, metabolic status, antiretroviral use, and HIV disease factors to endothelial dysfunction in HIV-infected subjects.Chronic HIV disease and activation of the coagulation systemRelationship between microbial translocation and endothelial function in HIV infected patients.Retinal arterioles narrow with increasing duration of anti-retroviral therapy in HIV infection: a novel estimator of vascular risk in HIV?Cardiovascular implications from untreated human immunodeficiency virus infection.Assessment of arterial elasticity among HIV-positive participants with high CD4 cell counts: a substudy of the INSIGHT Strategic Timing of AntiRetroviral Treatment (START) trial.HIV-Associated Venous ThromboembolismComparison of Rates of Death Having any Death-Certificate Mention of Heart, Kidney, or Liver Disease Among Persons Diagnosed with HIV Infection with those in the General US Population, 2009-2011Insulin resistance predicts endothelial dysfunction and cardiovascular risk in HIV-infected persons on long-term highly active antiretroviral therapyCarotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.Neither proteinuria nor albuminuria is associated with endothelial dysfunction in HIV-infected patients without diabetes or hypertension.Current Efavirenz (EFV) or ritonavir-boosted lopinavir (LPV/r) use correlates with elevate markers of atherosclerosis in HIV-infected subjects in Addis Ababa, Ethiopia.HIV infection and coronary heart disease: an intersection of epidemicsHIV replication, inflammation, and the effect of starting antiretroviral therapy on plasma asymmetric dimethylarginine, a novel marker of endothelial dysfunction.HIV-1, reactive oxygen species, and vascular complicationsProteinuria and endothelial dysfunction in stable HIV-infected patients. A pilot study.Coagulation biomarkers predict disease progression in SIV-infected nonhuman primates.Association between Immune Markers and Surrogate Markers of Cardiovascular Disease in HIV Positive Patients: A Systematic Review.HIV infection and stroke: current perspectives and future directionsA randomized controlled trial assessing the effects of raltegravir intensification on endothelial function in treated HIV infection.Cardiovascular disease in HIV infection.Serum amyloid P (SAP) is associated with impaired brachial artery flow-mediated dilation in chronically HIV-1 infected adults on stable antiretroviral therapy
P2860
Q26851535-B540C348-96B7-47FC-A1C0-8129AFF16CD8Q26862601-7A1642D4-366F-48E9-908C-9F25A6061A18Q27006827-16257259-4A53-4BB2-91A4-C49B5FEC9BF1Q27024262-0417B506-3369-4C3E-BFF2-F4F822FB370FQ27026486-17E0CE1C-FA4C-46A3-9CC4-11E71E09111CQ28386344-03325767-7B43-4D36-8EF2-1BBC01813E50Q28473903-F6877983-F86A-4E89-9A38-17914FA5E4A3Q28728667-06D5D55D-4383-47CA-9853-432605CEF163Q30244368-F63662B8-F4B3-4916-9B2F-78B23D979A01Q30403465-407BFF43-C1CF-48AA-830E-B50990D0B3D3Q33567864-FE4FC524-E902-4E5F-8AA6-33898FB553B6Q33614424-D84E6249-6A52-46B8-8558-D14E6C4A9888Q33640874-FE28F4E7-150E-40E1-9F85-9070CFA76A52Q33713895-B7632A50-6B72-449F-B3A4-6E5846BFB2DDQ33889580-56889BDE-2F17-4FE8-863E-0427D1CA6BAEQ33991362-09EF9BD6-F019-4FE2-BB25-203BA6B027EFQ34056642-4664C106-73EE-415E-BDFA-31CB57C298D8Q34116810-6BE0FD20-B91E-4FF4-B5D0-E8EC689D2427Q34213862-CEA05EA9-62DE-4632-BAFD-DA8AD3E702B5Q34342368-AA7DFC74-B28F-49B4-8CA0-01E1C0F0B5AEQ34404759-82783930-6326-456A-94EC-0F5573DBEFC6Q34516572-09798721-38AB-40FB-B112-02245CDD8A19Q34793193-EA3EE53D-6289-4847-AB2D-E6A1537F6943Q35124958-59115C23-528B-4E3F-BE68-634FC6554141Q35153652-2258BFC9-F3C2-49A7-A18F-8E8313888120Q35157763-B7791CE9-FDD2-438F-85A5-9359CF681AACQ35194049-DC408BF2-A581-4649-820C-32791F0935C5Q35492436-1E5CB2CB-B8E0-4572-9952-A7F5749EF579Q35532872-7EC5246B-95FF-4AFC-94CF-36993D510386Q35542679-B25F735A-09F0-4F2A-A3BA-1E8E619CC624Q35949941-F2A773A2-1A6D-4751-8D34-1C8450BA67ABQ35989740-A878732D-8100-4B70-A4DE-CDD4251A889BQ36040759-B491EF4D-0981-4619-9BDD-13779C890982Q36091784-4EA0703C-03CD-4C2A-87FD-DAF28B667635Q36177904-08F2D350-B0B1-476B-B8D9-C19AC7F2AA04Q36249027-656A05EF-6BDE-45E0-80B8-D15E76DC5D6DQ36285922-798BF6C8-2703-4D6C-A386-3754EC3398AFQ36346646-4AF34673-3124-4156-91DF-B7CDB6DCD225Q36408675-700AF401-9DBF-4908-9B35-CAC9BDC0CA04Q36673883-5F365EB5-979A-4144-8429-ADED542CB58F
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 31 March 2006
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Endothelial function in HIV-infected persons.
@en
Endothelial function in HIV-infected persons.
@nl
type
label
Endothelial function in HIV-infected persons.
@en
Endothelial function in HIV-infected persons.
@nl
prefLabel
Endothelial function in HIV-infected persons.
@en
Endothelial function in HIV-infected persons.
@nl
P2093
P2860
P50
P356
P1476
Endothelial function in HIV-infected persons
@en
P2093
Anthony Solages
David J Thornton
Donald E Craven
Jessica Murray
P2860
P304
P356
10.1086/503261
P407
P577
2006-03-31T00:00:00Z